+7 (495) 925 06 34
Sign up to our newsletter to get the latest updates on your favourite topics from the Veterinary Medicine and Life
< back

Vaccine Against Mastitis in Cows Approved in Russia

The vaccine ‘Maskivak-EVA’ for the prevention of clinical and subclinical mastitis in cows has been authorized in Russia. It was developed by the Federal Center for Animal Health (FGBI ARRIAH) under Rosselkhoznadzor. There are no similar vaccines currently available on the Russian market, Ilya Chvala, the Deputy Director of FGBI ARRIAH, told Veterinary Medicine and Life.

Vaccine Against Mastitis in Cows Approved in Russia
Photo by Alexander Plonsky /V&L

“All registration procedures have been completed. The vaccine will soon be available on the commercial market. High demand for this vaccine is expected, based on feedback from livestock farms. It is a unique product in the Russian market, with no similar domestic alternatives currently available,” Ilya Chvala told V&L.

He also mentioned that the vaccine is specifically designed to prevent infectious mastitis and that the institution’s professionals spent several years studying livestock and dairy farms in order to develop it.  

In search of vaccine strains, scientists collected over 400 samples of biomaterial from cows, and pathogens were isolated in 75% of them.

The immunobiological’s antigenic composition includes inactivated bacterial cells of Streptococcus agalactiaeStreptococcus dysgalactiaeStreptococcus uberis, two strains of Staphylococcus aureusStaphylococcus hyicus, and two strains of Escherichia coli.

Besides that, seven more vaccines developed by the FGBI ARRIAH have been authorized in 2023:

- the ‘Carnican-4’ vaccine against canine distemper, canine enteric parvovirus and coronavirus, and canine adenovirus in dogs;

- the ‘ARRIAH-Bimivak’ vaccine against avian mycoplasmosis and infectious synovitis in poultry;

- the inactivated emulsion vaccine against infectious bursal disease and viral tenosynovitis in poultry (‘ARRIAH-IBD+ARV’);

- the live dry vaccine against Newcastle disease, based on the ‘ARRIAH NB-En’ strain;

- the ‘Carnifel-PCH’ vaccine, effective against feline panleukopenia, feline calicivirus, and feline viral rhinotracheitis

- the inactivated emulsion vaccine against Newcastle disease, infectious bronchitis in chickens (multi-strain), infectious bursal disease, and metapneumovirus infection in birds (‘ARRIAH-ND+IBC+IBD+aMPV’);

- the ‘Carnican-5’ vaccine against canine distemper, canine enteric parvovirus and coronavirus, canine adenovirus, and rabies in dogs.

Read more about
English version, 19 Dec 2023 03:14
Related articles:
Номер 4 (83) апрель 2024
Veterinary Medicine and Life newspaper
Subscription to the Veterinary Medicine and Life newspaper
Sign up to our newsletter to get the latest updates on your favourite topics from the Veterinary Medicine and Life